Home News

2017 first half results presentation

Operating revenues, growth data, profitability and the behavior of our products.

Wed, 26/07/2017 - 12:28 0 min
Download related document
No votes yet
 
Related
ROVI has commenced the marketing of its enoxaparin biosimilar in Spain
0 min
19/09/2018
Press release - Grant for research project
Awarded a partially refundable grant for research project: Bluespe
1 min
31/07/2018
Enervit exercises the purchase option on 1% of Enervit Nutrition, a joint...
0 min
27/07/2018